Table 3.
Comparison of the present study with other solid-phase extraction methods for analysis of multi-class pollutants.
| Adsorbent/Method | Mass of Adsorbent (mg) | Analytes | LOD (µg L−1) | Linearity (µg L−1) | Correlation Coefficient (R2) | Refs. |
|---|---|---|---|---|---|---|
| MM-CMC/IT-SPME-HPLC-FLD | N/A | DANO, ENRO | 0.14–0.61 | 0.001–5.0 | 0.9980 | [51] |
| Oasis HLB-SPE-LC/MS/MS | 60 | Atenolol, carbamazepine | 1.01–69.30 | 1.87–138.6 | 0.9669–0.9999 | [52] |
| Carbowax 20M/FPSE/GC-MS | Not indicated | EP, BP | 0.009–0.021 | 0,05–500 | 0.9992–0.9997 | [22] |
| OasisHLB/ RDSE/GC-MS | 40 | MP, EP, PP, BP | 0.02–0.15 | 0.06–0.44 | 0.9904–0.9989 | [23] |
| Mixed mode cationic exchange cartidges (MXC) | 60 | MP | 0.01 | 0.06–1122 | 0.9999 | [1] |
| C18,Floracil, QuEChERS/UPLC-QqQ-MS | 50 mg | Beta-blockers: Atenolol, propranolol; Preservatives: BP, MP, PP; Anticonvulsant: carbamazepine | 0.093–0.12 | 1.0–200.0 | >0.95 | [53] |
| MMPC/Cyc-Chit/HPLC-DAD | 50 mg | Beta-blockers: atenolol, propranolol | 0.0001–0.0007 | LOQ-400 | 0.9987–0.9991 | This work |
| Parabens: MP, EP, PP, BP | 0.0001–0.0007 | LOQ-300 | 0.9987–0.9993 | |||
| Anticonvulsant: carbamazepine | 0.0003 | LOQ-350 | 0.9989 | |||
| Quinolones: DANO, LEVO, ENRO | 0.00045–0.0011 | LOQ-1000 | 0.9987–0.9990 |